FINWIRES · TerminalLIVE
FINWIRES

研究快讯:Cof:第一季度盈利不及预期,净息差令人失望

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:COF公布了2026年第一季度业绩,结果喜忧参半。其运营每股收益为4.42美元,低于去年同期的4.06美元,比市场预期低0.15美元,连续第二个季度未达预期。营收为152亿美元,也比预期低1.34亿美元。由于对Discover Financial的收购已于2025年5月18日完成,因此该业绩不具有直接可比性。在竞争激烈的存款定价环境下,净息差收窄39个基点至7.87%,但仍远高于收购Discover之前的水平。总净收入环比下降2%。信贷损失准备金小幅下降至41亿美元,而逾期30天以上的贷款率下降35个基点至3.24%,表明信贷质量未来可能有所改善。期末贷款余额下降1%至4480亿美元,反映出信贷选择性收紧的持续态势;存款余额增长3%至4890亿美元,提供了稳定的资金来源。14.4%的CET1比率远高于监管要求,为未来的增长和资本回报提供了充足的灵活性。

Related Articles

Asia

Easou Technology Invests $7.7 Million in Wealth Product Using Idle Top-up Placing Funds

Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.

$HKG:2550
Asia

SSY Group Gets Chinese Regulatory Nod for Production, Registration of Two Products

SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.

$HKG:2005
Asia

Amplitude Energy Says Australian Retirement Trust Raises Stake

Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.

$ASX:AEL